The global Artemisinine market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 78 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Artemisinine Market

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

This report aims to provide a comprehensive presentation of the global market for Artemisinine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinine.

Report Scope

The Artemisinine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Artemisinine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Artemisinine Market Report

Report Metric	Details
Report Name	Artemisinine Market
Accounted market size in 2023	US$ 62 million
Forecasted market size in 2030	US$ 78 million
CAGR	3.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Extraction from Artemisia annua Semisynthetic Artemisinine
Segment by Application	Injections Tablets Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemisinine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Artemisinine Market growing?

Ans: The Artemisinine Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Artemisinine Market size in 2030?

Ans: The Artemisinine Market size in 2030 will be US$ 78 million.

What is the market share of major companies in Artemisinine Market?

Ans: Global top four manufacturers hold a share over 65%.

What is the Artemisinine Market share by region?

Ans: Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

What is the Artemisinine Market share by type?

Ans: In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%.

Who are the main players in the Artemisinine Market report?

Ans: The main players in the Artemisinine Market are Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai

What are the Application segmentation covered in the Artemisinine Market report?

Ans: The Applications covered in the Artemisinine Market report are Injections, Tablets, Others

What are the Type segmentation covered in the Artemisinine Market report?

Ans: The Types covered in the Artemisinine Market report are Extraction from Artemisia annua, Semisynthetic Artemisinine

1 Artemisinine Market Overview

1.1 Product Overview and Scope of Artemisinine

1.2 Artemisinine Segment by Type

1.2.1 Global Artemisinine Market Value Comparison by Type (2024-2030)

1.2.2 Extraction from Artemisia annua

1.2.3 Semisynthetic Artemisinine

1.3 Artemisinine Segment by Application

1.3.1 Global Artemisinine Market Value by Application: (2024-2030)

1.3.2 Injections

1.3.3 Tablets

1.3.4 Others

1.4 Global Artemisinine Market Size Estimates and Forecasts

1.4.1 Global Artemisinine Revenue 2019-2030

1.4.2 Global Artemisinine Sales 2019-2030

1.4.3 Global Artemisinine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Artemisinine Market Competition by Manufacturers

2.1 Global Artemisinine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Artemisinine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Artemisinine Average Price by Manufacturers (2019-2024)

2.4 Global Artemisinine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Artemisinine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Artemisinine, Product Type & Application

2.7 Artemisinine Market Competitive Situation and Trends

2.7.1 Artemisinine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Artemisinine Players Market Share by Revenue

2.7.3 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artemisinine Retrospective Market Scenario by Region

3.1 Global Artemisinine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Artemisinine Global Artemisinine Sales by Region: 2019-2030

3.2.1 Global Artemisinine Sales by Region: 2019-2024

3.2.2 Global Artemisinine Sales by Region: 2025-2030

3.3 Global Artemisinine Global Artemisinine Revenue by Region: 2019-2030

3.3.1 Global Artemisinine Revenue by Region: 2019-2024

3.3.2 Global Artemisinine Revenue by Region: 2025-2030

3.4 North America Artemisinine Market Facts & Figures by Country

3.4.1 North America Artemisinine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Artemisinine Sales by Country (2019-2030)

3.4.3 North America Artemisinine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Artemisinine Market Facts & Figures by Country

3.5.1 Europe Artemisinine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Artemisinine Sales by Country (2019-2030)

3.5.3 Europe Artemisinine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Artemisinine Market Facts & Figures by Country

3.6.1 Asia Pacific Artemisinine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Artemisinine Sales by Country (2019-2030)

3.6.3 Asia Pacific Artemisinine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Artemisinine Market Facts & Figures by Country

3.7.1 Latin America Artemisinine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Artemisinine Sales by Country (2019-2030)

3.7.3 Latin America Artemisinine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Artemisinine Market Facts & Figures by Country

3.8.1 Middle East and Africa Artemisinine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Artemisinine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Artemisinine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Artemisinine Sales by Type (2019-2030)

4.1.1 Global Artemisinine Sales by Type (2019-2024)

4.1.2 Global Artemisinine Sales by Type (2025-2030)

4.1.3 Global Artemisinine Sales Market Share by Type (2019-2030)

4.2 Global Artemisinine Revenue by Type (2019-2030)

4.2.1 Global Artemisinine Revenue by Type (2019-2024)

4.2.2 Global Artemisinine Revenue by Type (2025-2030)

4.2.3 Global Artemisinine Revenue Market Share by Type (2019-2030)

4.3 Global Artemisinine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Artemisinine Sales by Application (2019-2030)

5.1.1 Global Artemisinine Sales by Application (2019-2024)

5.1.2 Global Artemisinine Sales by Application (2025-2030)

5.1.3 Global Artemisinine Sales Market Share by Application (2019-2030)

5.2 Global Artemisinine Revenue by Application (2019-2030)

5.2.1 Global Artemisinine Revenue by Application (2019-2024)

5.2.2 Global Artemisinine Revenue by Application (2025-2030)

5.2.3 Global Artemisinine Revenue Market Share by Application (2019-2030)

5.3 Global Artemisinine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Guilin Pharmaceutical

6.1.1 Guilin Pharmaceutical Corporation Information

6.1.2 Guilin Pharmaceutical Description and Business Overview

6.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Guilin Pharmaceutical Artemisinine Product Portfolio

6.1.5 Guilin Pharmaceutical Recent Developments/Updates

6.2 CAT KHANH

6.2.1 CAT KHANH Corporation Information

6.2.2 CAT KHANH Description and Business Overview

6.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 CAT KHANH Artemisinine Product Portfolio

6.2.5 CAT KHANH Recent Developments/Updates

6.3 Novanat Bioresource

6.3.1 Novanat Bioresource Corporation Information

6.3.2 Novanat Bioresource Description and Business Overview

6.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novanat Bioresource Artemisinine Product Portfolio

6.3.5 Novanat Bioresource Recent Developments/Updates

6.4 BEEPZ

6.4.1 BEEPZ Corporation Information

6.4.2 BEEPZ Description and Business Overview

6.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 BEEPZ Artemisinine Product Portfolio

6.4.5 BEEPZ Recent Developments/Updates

6.5 KPC Pharmaceuticals

6.5.1 KPC Pharmaceuticals Corporation Information

6.5.2 KPC Pharmaceuticals Description and Business Overview

6.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 KPC Pharmaceuticals Artemisinine Product Portfolio

6.5.5 KPC Pharmaceuticals Recent Developments/Updates

6.6 BIONEXX

6.6.1 BIONEXX Corporation Information

6.6.2 BIONEXX Description and Business Overview

6.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 BIONEXX Artemisinine Product Portfolio

6.6.5 BIONEXX Recent Developments/Updates

6.7 Guangxi xiancaotang

6.6.1 Guangxi xiancaotang Corporation Information

6.6.2 Guangxi xiancaotang Description and Business Overview

6.6.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Guangxi xiancaotang Artemisinine Product Portfolio

6.7.5 Guangxi xiancaotang Recent Developments/Updates

6.8 Sanofi

6.8.1 Sanofi Corporation Information

6.8.2 Sanofi Description and Business Overview

6.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sanofi Artemisinine Product Portfolio

6.8.5 Sanofi Recent Developments/Updates

6.9 Natural Bio-engineering

6.9.1 Natural Bio-engineering Corporation Information

6.9.2 Natural Bio-engineering Description and Business Overview

6.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Natural Bio-engineering Artemisinine Product Portfolio

6.9.5 Natural Bio-engineering Recent Developments/Updates

6.10 Kerui nanhai

6.10.1 Kerui nanhai Corporation Information

6.10.2 Kerui nanhai Description and Business Overview

6.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Kerui nanhai Artemisinine Product Portfolio

6.10.5 Kerui nanhai Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Artemisinine Industry Chain Analysis

7.2 Artemisinine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Artemisinine Production Mode & Process

7.4 Artemisinine Sales and Marketing

7.4.1 Artemisinine Sales Channels

7.4.2 Artemisinine Distributors

7.5 Artemisinine Customers

8 Artemisinine Market Dynamics

8.1 Artemisinine Industry Trends

8.2 Artemisinine Market Drivers

8.3 Artemisinine Market Challenges

8.4 Artemisinine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Guilin Pharmaceutical

Natural Bio-engineering

Kerui nanhai

List of Tables

Table 1. Global Artemisinine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Artemisinine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Artemisinine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Artemisinine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Artemisinine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Artemisinine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Artemisinine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Artemisinine Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Artemisinine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Artemisinine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Artemisinine, Product Type & Application

Table 12. Global Key Manufacturers of Artemisinine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Artemisinine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Artemisinine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Artemisinine Sales by Region (2019-2024) & (K Units)

Table 18. Global Artemisinine Sales Market Share by Region (2019-2024)

Table 19. Global Artemisinine Sales by Region (2025-2030) & (K Units)

Table 20. Global Artemisinine Sales Market Share by Region (2025-2030)

Table 21. Global Artemisinine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Artemisinine Revenue Market Share by Region (2019-2024)

Table 23. Global Artemisinine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Artemisinine Revenue Market Share by Region (2025-2030)

Table 25. North America Artemisinine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Artemisinine Sales by Country (2019-2024) & (K Units)

Table 27. North America Artemisinine Sales by Country (2025-2030) & (K Units)

Table 28. North America Artemisinine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Artemisinine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Artemisinine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Artemisinine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Artemisinine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Artemisinine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Artemisinine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Artemisinine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Artemisinine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Artemisinine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Artemisinine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Artemisinine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Artemisinine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Artemisinine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Artemisinine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Artemisinine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Artemisinine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Artemisinine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Artemisinine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Artemisinine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Artemisinine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Artemisinine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Artemisinine Sales (K Units) by Type (2019-2024)

Table 51. Global Artemisinine Sales (K Units) by Type (2025-2030)

Table 52. Global Artemisinine Sales Market Share by Type (2019-2024)

Table 53. Global Artemisinine Sales Market Share by Type (2025-2030)

Table 54. Global Artemisinine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Artemisinine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Artemisinine Revenue Market Share by Type (2019-2024)

Table 57. Global Artemisinine Revenue Market Share by Type (2025-2030)

Table 58. Global Artemisinine Price (USD/Unit) by Type (2019-2024)

Table 59. Global Artemisinine Price (USD/Unit) by Type (2025-2030)

Table 60. Global Artemisinine Sales (K Units) by Application (2019-2024)

Table 61. Global Artemisinine Sales (K Units) by Application (2025-2030)

Table 62. Global Artemisinine Sales Market Share by Application (2019-2024)

Table 63. Global Artemisinine Sales Market Share by Application (2025-2030)

Table 64. Global Artemisinine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Artemisinine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Artemisinine Revenue Market Share by Application (2019-2024)

Table 67. Global Artemisinine Revenue Market Share by Application (2025-2030)

Table 68. Global Artemisinine Price (USD/Unit) by Application (2019-2024)

Table 69. Global Artemisinine Price (USD/Unit) by Application (2025-2030)

Table 70. Guilin Pharmaceutical Corporation Information

Table 71. Guilin Pharmaceutical Description and Business Overview

Table 72. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Guilin Pharmaceutical Artemisinine Product

Table 74. Guilin Pharmaceutical Recent Developments/Updates

Table 75. CAT KHANH Corporation Information

Table 76. CAT KHANH Description and Business Overview

Table 77. CAT KHANH Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. CAT KHANH Artemisinine Product

Table 79. CAT KHANH Recent Developments/Updates

Table 80. Novanat Bioresource Corporation Information

Table 81. Novanat Bioresource Description and Business Overview

Table 82. Novanat Bioresource Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Novanat Bioresource Artemisinine Product

Table 84. Novanat Bioresource Recent Developments/Updates

Table 85. BEEPZ Corporation Information

Table 86. BEEPZ Description and Business Overview

Table 87. BEEPZ Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. BEEPZ Artemisinine Product

Table 89. BEEPZ Recent Developments/Updates

Table 90. KPC Pharmaceuticals Corporation Information

Table 91. KPC Pharmaceuticals Description and Business Overview

Table 92. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. KPC Pharmaceuticals Artemisinine Product

Table 94. KPC Pharmaceuticals Recent Developments/Updates

Table 95. BIONEXX Corporation Information

Table 96. BIONEXX Description and Business Overview

Table 97. BIONEXX Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. BIONEXX Artemisinine Product

Table 99. BIONEXX Recent Developments/Updates

Table 100. Guangxi xiancaotang Corporation Information

Table 101. Guangxi xiancaotang Description and Business Overview

Table 102. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Guangxi xiancaotang Artemisinine Product

Table 104. Guangxi xiancaotang Recent Developments/Updates

Table 105. Sanofi Corporation Information

Table 106. Sanofi Description and Business Overview

Table 107. Sanofi Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Sanofi Artemisinine Product

Table 109. Sanofi Recent Developments/Updates

Table 110. Natural Bio-engineering Corporation Information

Table 111. Natural Bio-engineering Description and Business Overview

Table 112. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Natural Bio-engineering Artemisinine Product

Table 114. Natural Bio-engineering Recent Developments/Updates

Table 115. Kerui nanhai Corporation Information

Table 116. Kerui nanhai Description and Business Overview

Table 117. Kerui nanhai Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Kerui nanhai Artemisinine Product

Table 119. Kerui nanhai Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Artemisinine Distributors List

Table 123. Artemisinine Customers List

Table 124. Artemisinine Market Trends

Table 125. Artemisinine Market Drivers

Table 126. Artemisinine Market Challenges

Table 127. Artemisinine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Artemisinine

Figure 2. Global Artemisinine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Artemisinine Market Share by Type in 2023 & 2030

Figure 4. Extraction from Artemisia annua Product Picture

Figure 5. Semisynthetic Artemisinine Product Picture

Figure 6. Global Artemisinine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Artemisinine Market Share by Application in 2023 & 2030

Figure 8. Injections

Figure 9. Tablets

Figure 10. Others

Figure 11. Global Artemisinine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Artemisinine Market Size (2019-2030) & (US$ Million)

Figure 13. Global Artemisinine Sales (2019-2030) & (K Units)

Figure 14. Global Artemisinine Average Price (USD/Unit) & (2019-2030)

Figure 15. Artemisinine Report Years Considered

Figure 16. Artemisinine Sales Share by Manufacturers in 2023

Figure 17. Global Artemisinine Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Artemisinine Players: Market Share by Revenue in 2023

Figure 19. Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Artemisinine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Artemisinine Sales Market Share by Country (2019-2030)

Figure 22. North America Artemisinine Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Artemisinine Sales Market Share by Country (2019-2030)

Figure 26. Europe Artemisinine Revenue Market Share by Country (2019-2030)

Figure 27. Germany Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Artemisinine Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Artemisinine Revenue Market Share by Region (2019-2030)

Figure 34. China Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Artemisinine Sales Market Share by Country (2019-2030)

Figure 45. Latin America Artemisinine Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Artemisinine Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Artemisinine Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Artemisinine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Artemisinine by Type (2019-2030)

Figure 55. Global Revenue Market Share of Artemisinine by Type (2019-2030)

Figure 56. Global Artemisinine Price (USD/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Artemisinine by Application (2019-2030)

Figure 58. Global Revenue Market Share of Artemisinine by Application (2019-2030)

Figure 59. Global Artemisinine Price (USD/Unit) by Application (2019-2030)

Figure 60. Artemisinine Value Chain

Figure 61. Artemisinine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-7U13932

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Oral Antifungals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-27S13086

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Human Whole Blood - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19N13792

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Immune Thrombocytopenia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-24G3922

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Artemisinine Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-5L3017

Global Artemisinine Market Research Report 2024

FEATURED COMPANIES

Artemisinine Market Size

Artemisinine Market

Report Scope

Scope of Artemisinine Market Report

Chapter Outline

FAQ for this report

How fast is Artemisinine Market growing?

What is the Artemisinine Market size in 2030?

What is the market share of major companies in Artemisinine Market?

What is the Artemisinine Market share by region?

What is the Artemisinine Market share by type?

Who are the main players in the Artemisinine Market report?

What are the Application segmentation covered in the Artemisinine Market report?

What are the Type segmentation covered in the Artemisinine Market report?

FEATURED COMPANIES

RELATED REPORTS